Publication: Effects of carbohydrate reduction program and telemonitoring on glycosylated hemoglobin in patients with poorly controlled type 2 diabetes: A randomized controlled trial
Issued Date
2019-05-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-85068805980
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.102, No.5 (2019), 523-529
Suggested Citation
R. Jantraporn, P. Pichayapinyo, S. Lagampan, K. Mayurasakorn Effects of carbohydrate reduction program and telemonitoring on glycosylated hemoglobin in patients with poorly controlled type 2 diabetes: A randomized controlled trial. Journal of the Medical Association of Thailand. Vol.102, No.5 (2019), 523-529. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/51654
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Effects of carbohydrate reduction program and telemonitoring on glycosylated hemoglobin in patients with poorly controlled type 2 diabetes: A randomized controlled trial
Other Contributor(s)
Abstract
© JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND | 2019. Objective: To examine whether a carbohydrate reduction program combined with telemonitoring improves glycosylated hemoglobin (HbA1c) in patients with poorly controlled type 2 diabetes. Materials and Methods: A randomized controlled trial with two-group pretest-posttest design and follow-up was conducted in the Primary Care Unit at Siriraj Hospital, Bangkok, Thailand. Fifty-three patients with poorly controlled type 2 diabetes aged from 35 to 59 years were randomly assigned to two groups, an experimental group (n = 26) that received both routine care and a dietary carbohydrate program applying telephone monitoring, and a comparison group (n = 27) that received only routine care. HbA1c was assessed at baseline and at 12 weeks. Dietary self-efficacy and consumption behavior were measured at baseline, 8 weeks, and 12 weeks. Results: According to the findings, the HbA1c levels in the experimental group at 12 weeks showed significant improvement compared to baseline and the comparison group (p<0.05). The mean difference in dietary self-efficacy and consumption behavior at 12-week were significantly higher than baseline and greater than those in the comparison group (p<0.05). Conclusion: The study program was effective in decreasing HbA1c levels because the program enhanced patients’ confidence in dietary control, which improved consumption behavior.